Skip to main content
Research_

Deciphering the metabolomics signature of common eye diseases to discover early blood markers and pathogenic pathways

metabolomics technology used to determine the metabolite profiles and disruption of metabolite pathways
The use of novel metabolomics technology to determine the metabolite profiles and disruption of metabolite pathways in people with and without eye disease

This study will use novel metabolomics technology to determine the metabolite profiles and disruption of metabolite pathways in people with and without eye diseases such as macular degeneration and diabetic retinopathy. Metabolomics refers to the study of the set of small molecule metabolites (eg. lipids, amino acids, sugars , etc.)that are disordered in disease. The results obtained may provide an early blood marker that can detect people who go on to develop these eye diseases.

If you volunteer for this study you will be required to complete a demographics and lifestyle questionnaire and a food frequency questionnaire and provide a blood and urine sample for metabolomics analyses. There is no follow-up to this study.

 

Ethics approval number: 2016/068  

Eligibility

You may be eligible to participate in this study if you:

  • Aged 50 years or over
  • Have no disease in the back of the eye (the retina), including macular degeneration, diabetic retinopathy, glaucoma, retina artery or vein occlusions, macular holes or retinitis pigmentosa.

How to participate

If you are interested in participating or finding out more about this study please contact Nichole Joachim by Phone: (02)8627 3365 or by email here